Targeting of HIF-α to the von Hippel-Lindau ubiquitylation complex by O2-regulated prolyl hydroxylation

被引:4539
|
作者
Jaakkola, P
Mole, DR
Tian, YM
Wilson, MI
Gielbert, J
Gaskell, SJ
von Kriegsheim, A
Hebestreit, HF
Mukherji, M
Schofield, CJ
Maxwell, PH
Pugh, CW
Ratcliffe, PJ
机构
[1] Univ Oxford, Oxford OX3 7BN, England
[2] Univ Manchester, Inst Sci & Technol, Dept Chem, Michael Barber Ctr Mass Spectrometry, Manchester M60 1QD, Lancs, England
[3] Univ Oxford, Glycobiol Inst, Oxford OX1 3QU, England
[4] Univ Oxford, Dyson Perrins Lab, Oxford Ctr Mol Sci, Oxford OX1 3QY, England
关键词
D O I
10.1126/science.1059796
中图分类号
O [数理科学和化学]; P [天文学、地球科学]; Q [生物科学]; N [自然科学总论];
学科分类号
07 ; 0710 ; 09 ;
摘要
Hypoxia-inducible factor (HIF) is a transcriptional complex that plays a central role in the regulation of gene expression by oxygen. In oxygenated and iron replete cells, HIF-alpha subunits are rapidly destroyed by a mechanism that involves ubiquitylation by the von Hippel-Lindau tumor suppressor (pVHL) E3 Ligase complex. This process is suppressed by hypoxia and iron chelation, allowing transcriptional activation. Here we show that the interaction between human pVHL and a specific domain of the HIF-1 alpha subunit is regulated through hydroxylation of a proline residue (HIF-1 alpha P564) by an enzyme we have termed HIF-alpha prolyl-hydroxylase (HIF-PH). An absolute requirement for dioxygen as a cosubstrate and iron as cofactor suggests that HIF-PH functions directly as a cellular oxygen sensor.
引用
收藏
页码:468 / 472
页数:5
相关论文
共 49 条
  • [31] Carboxyl-terminal transactivation activity of hypoxia-inducible factor 1α is governed by a von Hippel-Lindau protein-independent, hydroxylation-regulated association with p300/CBP
    Sang, NL
    Fang, J
    Srinivas, V
    Leshchinsky, I
    Caro, J
    MOLECULAR AND CELLULAR BIOLOGY, 2002, 22 (09) : 2984 - 2992
  • [32] BPI-452080: A potent and selective HIF-2α inhibitor for the treatment of clear cell renal cell carcinoma, von Hippel-Lindau disease, and other solid tumors
    Wang, Pingping
    Yang, Rongwen
    Sun, Yun
    Ju, Xuepeng
    Zhao, Jiayu
    Liu, Yanju
    Liu, Xiaoyun
    Zou, Zhengyao
    Ren, Jialin
    Wang, Min
    Chen, Haibo
    Yi, Xuegang
    Zhang, Jian
    Ma, Teng
    Cheng, Gaoliang
    Liu, Lijia
    Guo, Jing
    Liu, Xiangyong
    Lan, Hong
    Ding, Lieming
    Wang, Jiabing
    CANCER RESEARCH, 2023, 83 (07)
  • [33] Loss of von Hippel-Lindau Protein (VHL) Increases Systemic Cholesterol Levels through Targeting Hypoxia-Inducible Factor 2α and Regulation of Bile Acid Homeostasis
    Ramakrishnan, Sadeesh K.
    Taylor, Matthew
    Qu, Aijuan
    Ahn, Sung-Hoon
    Suresh, Madathilparambil V.
    Raghavendran, Krishnan
    Gonzalez, Frank J.
    Shah, Yatrik M.
    MOLECULAR AND CELLULAR BIOLOGY, 2014, 34 (07) : 1208 - 1220
  • [34] Ocular findings in a phase 2 trial testing the first-in-class oral HIF-2α inhibitor, PT2385, for renal cell carcinoma in von Hippel-Lindau disease
    Wiley, Henry
    Srinivasan, Ramaprasad
    Linehan, Marston
    Cukras, Catherine A.
    Keenan, Tiarnan D. L.
    Wong, Wai T.
    Chew, Emily Y.
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2019, 60 (09)
  • [35] Up-regulation of hypoxia-inducible factors HIF-1α and HIF-2α under normoxic conditions in renal carcinoma cells by von Hippel-Lindau tumor suppressor gene loss of function
    Marion Krieg
    Richard Haas
    Hiltrud Brauch
    Till Acker
    Ingo Flamme
    Karl H Plate
    Oncogene, 2000, 19 : 5435 - 5443
  • [36] Up-regulation of hypoxia-inducible factors HIF-1α and HIF-2α under normoxic conditions in renal carcinoma cells by von Hippel-Lindau tumor suppressor gene loss of function
    Krieg, M
    Haas, R
    Brauch, H
    Acker, T
    Flamme, I
    Plate, KH
    ONCOGENE, 2000, 19 (48) : 5435 - 5443
  • [37] The von Hippel-Lindau tumor-suppressor gene product forms a stable complex with human CUL-2, a member of the Cdc53 family of proteins
    Pause, A
    Lee, S
    Worrell, RA
    Chen, DYT
    Burgess, WH
    Linehan, WM
    Klausner, RD
    PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1997, 94 (06) : 2156 - 2161
  • [38] Phosphorylation of the von Hippel-Lindau protein (VHL) by protein kinase CK2 reduces its protein stability and affects p53 and HIF-1α mediated transcription
    Ampofo, Emmanuel
    Kietzmann, Thomas
    Zimmer, Andreas
    Jakupovic, Mirza
    Montenarh, Mathias
    Goetz, Claudia
    INTERNATIONAL JOURNAL OF BIOCHEMISTRY & CELL BIOLOGY, 2010, 42 (10): : 1729 - 1735
  • [39] Belzutifan, a HIF-2α Inhibitor, for von Hippel-Lindau (VHL) disease-associated neoplasms: 36 months of follow-up of the phase II LITESPARK-004 study
    Srinivasan, R.
    Iliopoulos, O.
    Rathmell, W. K.
    Narayan, V.
    Maughan, B. L.
    Oudard, S.
    Else, T.
    Maranchie, J. K.
    Welsh, S. J.
    Iversen, A. B. Bondergaard
    Chen, K.
    Perini, R. F.
    Liu, Y.
    Linehan, W. M.
    Jonasch, E.
    ANNALS OF ONCOLOGY, 2022, 33 (07) : S1433 - S1434
  • [40] LOSS OF VON HIPPEL-LINDAU TUMOUR SUPPRESSOR PROTEIN IN RENAL CELL CARCINOMA CELLS ENHANCES SUSCEPTIBILITY TO ENCEPHALOMYOCARDITIS VIRUS VIA HIF2α-AND NFκB-DEPENDENT MECHANISM
    Roos, F. C.
    Huang, I. I. L.
    Roberts, A. M.
    Watson, I. R.
    Carniero, L.
    Girardin, S.
    Bell, J. C.
    Brenner, W.
    Thueroff, J. W.
    Ohh, M.
    EUROPEAN UROLOGY SUPPLEMENTS, 2010, 9 (02) : 194 - 195